Tratamiento farmacológico del trastorno depresivo mayor en adultos

Nuria Martín Cardenal

Nuria Martín Cardenal Medicina Familiar y Comunitaria. Hospital Universitario Torrejón de Ardoz, Madrid

Palabras clave: Depresión Mayor, Farmacoterapia, Antidepresivos, Antipsicóticos

Abstract

La Red Canadiense para el Tratamiento del Estado de Ánimo y Ansiedad (CANMAT) realizó una revisión de la guía de 2009 para actualizar la evidencia y las recomendaciones del tratamiento farmacológico. Las directrices de 2016 continúan siendo el tratamiento del trastorno depresivo mayor en adultos, dirigido a psiquiatras y otros profesionales de la salud mental.

Citas

Vol 117, Nº 1, Págs 26-43. 2009. Kennedy SH, Lam RW, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord. Doi: https://doi.org/10.1016/j.jad.2009.06.041

Vol 21, Nº 4, Págs 523-530. 2016. Hieronymus F, Emilsson JF, Nilsson S, et al. Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression. Mol Psychiatry. Doi: https://doi.org/10.1038/mp.2015.53

Vol 201, Nº 9, Págs 727-729. 2013. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed Arlington (VA): APA. Doi: https://doi.org/10.1097/NMD.0b013e3182a2168a

Vol 76, Nº8, págs. 1050-1059. 2015. Kronstein PD, Ishida E, Khin NA, et al. Summary of findings from the FDA regulatory science forum on measuring sexual dysfunction in depression trials. Journal of Clinical Psychiatry.

Vol 61, Nº9, págs 506-509. 2016. Lam RW, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: introduction and methods. Can J Psychiatry. Doi: https://doi.org/10.1177/0706743716659061

Vol 125, Nº9, págs 859-868. 2012. Vieweg WV, Hasnain M, Howland RH, et al. Citalopram, QTc interval prolongation, and torsade de pointes: how should we apply the recent FDA ruling? Am J Med. 2012; 125:859–868. [PubMed] [Google Scholar]. Doi: https://doi.org/10.1016/j.amjmed.2011.12.002

Vol 28, Nº 7, págs 601-609. 2014. Kudlow PA, McIntyre RS, Lam RW. Early switching strategies in antidepressant non-responders: current evidence and future research directions. CNS Drugs.